Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
about
Re-Use of Established Drugs for Anti-Metastatic IndicationsImpact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studiesSympathetic nervous system regulation of the tumour microenvironmentNeural Regulation of Pancreatic Cancer: A Novel Target for InterventionRepurposing of approved cardiovascular drugsA network-based classification model for deriving novel drug-disease associations and assessing their molecular actionsAnalysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancerPre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort studyβ-blockers: a new role in cancer chemotherapy?A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseMeta-analysis of the effects of beta blocker on survival time in cancer patients.Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patientsChronic stress, sympathetic activation and skeletal metastasis of breast cancer cells.Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.Stress, metabolism and cancer: integrated pathways contributing to immune suppressionTherapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptidesPrognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationBehavioral research in cancer prevention and control: a look to the future.Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation.The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentSurvivorship issues for patients with lung cancer.Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice.β-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy.The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.Essential Neuroscience in Immunology.Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice.Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs.
P2860
Q26771704-D1920863-B93F-4F2D-8FCA-B907FD1AEA2AQ26777142-18033BFA-5C47-4333-BA1F-32AA0EC69824Q26795614-83560820-55E3-4C94-9FB7-EEA84B455DB8Q26801748-4E505F15-9B12-4503-8973-892A83CB962EQ28074453-1790472C-BFC3-4A74-B8F5-0C00A0BF85EAQ28544627-F543D29F-5F6E-4317-BE62-63E2E8B57E27Q33622701-6C64DBA7-0636-492A-AE7D-46728B7E17B3Q33767409-6967A621-CA00-4F07-A22E-5464288BA289Q34086281-F660D602-50EE-45E4-9A87-8CCE4D3E0174Q35077524-E4F1E322-015C-4504-9A43-6DB4DCE774C8Q35132413-65350C55-3EEB-4690-A04A-ED4CB9B1600BQ35586501-45BD76FC-6DCB-4CA6-A457-84C7BC60436EQ35609448-EDFCC583-817F-48B9-B27B-64259F2E889CQ35754482-CEEB65B0-8461-4D8D-B546-986C9C4AA4E1Q35755577-17D9C67F-6F98-4F5D-B8CE-E7D2DF9FE526Q35915762-DCD9CF5F-9BFD-41F4-9A4D-9A5178FAD2B3Q36145501-F376A3CB-EA55-4DF9-8833-F3E73CB26359Q36194450-5F1872C5-BFFD-4DC6-BA23-82CDC2062FFAQ36568221-53DDBA66-1535-4111-8763-DEF13298DB86Q36805595-23C3F87B-516D-4C40-B799-CF6872434D5AQ36959073-559B2FC1-4CD0-4E3D-9251-69CBC3D757F0Q37565625-1E839057-DA46-43C0-9F06-1E8103576205Q37578948-7CA05358-B321-4164-A807-86E62E083FBEQ37649652-5E7F9306-F822-487C-8D94-CEF55B8706FFQ37688636-2E96E425-9C3B-418D-B209-8EF3F92BFC6AQ37693485-D9D83EBD-4116-4156-ADB2-75AA099327B5Q38172916-75681307-5A0B-47AC-A728-B877EE1B0E80Q38293740-8A5F9F53-2B1A-42C2-BFA4-792996577294Q38406732-014B44BE-987B-4662-A57F-D21D079C3F4DQ38420970-F7954801-0F4F-4841-B840-D46C59584AA2Q38619196-41E7ACC4-DCC5-47B5-AF47-B4138F3E4D0DQ38664877-4A3E3A10-89A3-4FEF-8B85-16ABAB3E79B3Q38742275-30ADDD30-60B4-496F-95E7-1D0C402C1967Q38745611-F8EB296D-1DEA-4EE1-B153-FBFA6816886BQ38781876-FFB12B89-FB0C-40A5-97B4-C74BA39E5620Q39247074-3AC55AFF-651C-435E-811B-F280E0EA8BFFQ39391997-1223336D-7D1D-41FB-AB48-48906CA7F639Q40458341-B868FFF9-F319-400E-BD9B-B3E15609B905Q41919001-57CA91FD-2939-481C-BD0F-649FD57AA20FQ42957826-B8E7B34B-14A3-4A90-8DDF-58BD01BE4BAA
P2860
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Improved survival outcomes wit ...... definitive radiation therapy.
@ast
Improved survival outcomes wit ...... definitive radiation therapy.
@en
type
label
Improved survival outcomes wit ...... definitive radiation therapy.
@ast
Improved survival outcomes wit ...... definitive radiation therapy.
@en
prefLabel
Improved survival outcomes wit ...... definitive radiation therapy.
@ast
Improved survival outcomes wit ...... definitive radiation therapy.
@en
P2093
P2860
P356
P1433
P1476
Improved survival outcomes wit ...... definitive radiation therapy.
@en
P2093
M S O'Reilly
P2860
P304
P356
10.1093/ANNONC/MDS616
P577
2013-01-08T00:00:00Z